ITCI

Intra-Cellular Therapies Inc.

Delisted

ITCI was delisted on the 1st of April, 2025.

4 hedge funds and large institutions have $4.2M invested in Intra-Cellular Therapies Inc. in 2025 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 385 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
4
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$12.9K
Name Holding Trade Value Shares
Change
Change in
Stake
FT
301
Fiduciary Trust
Massachusetts
SWM
302
SeaCrest Wealth Management
New York
PCM
303
PenderFund Capital Management
British Columbia, Canada
CF
304
Corebridge Financial
Texas
SWA
305
SFMG Wealth Advisors
Texas
PCM
306
Polymer Capital Management
New York
CI Investments Inc
307
CI Investments Inc
Ontario, Canada
Raymond James Financial
308
Raymond James Financial
Florida
CPA
309
Capital Performance Advisors
California
CGH
310
Crossmark Global Holdings
Texas
CCM
311
Coldstream Capital Management
Washington
VA
312
Vident Advisory
Georgia
TRCT
313
Tower Research Capital (TRC)
New York
WMA
314
West Michigan Advisors
Michigan
CSP
315
Cary Street Partners
Virginia
BCM
316
Blume Capital Management
California
C
317
Covestor
United Kingdom
GWSG
318
GPS Wealth Strategies Group
Colorado
FFA
319
Farther Finance Advisors
California
S
320
SignatureFD
Georgia
GI
321
GAMMA Investing
California
GWM
322
Geneos Wealth Management
Colorado
LIM
323
Longfellow Investment Management
Massachusetts
TWD
324
True Wealth Design
Ohio
EWA
325
EverSource Wealth Advisors
Alabama